Differences in cholesterol management among states in relation to health insurance and race/ethnicity across the United States

被引:7
作者
Hsia, Stanley H. [1 ]
DesNoyers, Monica L. [1 ]
Lee, Martin L. [1 ,2 ]
机构
[1] Charles R Drew Univ Med & Sci, Dept Internal Med, Div Endocrinol Metab & Mol Med, Los Angeles, CA 90059 USA
[2] Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90024 USA
关键词
Cholesterol screening; Ethnicity; Health insurance; HMG-CoA reductase inhibitors; Lipid lowering medications; Race;
D O I
10.1016/j.jacl.2013.03.010
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
BACKGROUND: Across the United States, hyperlipidemia remains inadequately controlled and may vary across states according to differences in health insurance coverage and/or race/ethnicity. OBJECTIVE: To examine relationships between states' health insurance and race/ethnicity characteristics with measures of hyperlipidemia management across the 50 U.S. states and the District of Columbia. METHODS: Cross-validated, multiple linear regression modeling was used to analyze associations between states' health insurance patterns or proportions of racial minorities (from the 2010 U.S. Census data) and states' aggregate frequency of checking cholesterol within the previous 5 years or prescriptions written for lipid-lowering medications (from national survey and population-adjusted retail prescription data, respectively), with adjustments for age, sex, body mass index, race/ethnicity, and poverty. RESULTS: In states with proportionately more uninsured, cholesterol levels are checked less often, but in states with proportionately more private, Medicare, or Medicaid coverage, providers are not necessarily more likely to check cholesterol or to write more prescriptions. In states with proportionately more African-Americans and/or Hispanics, cholesterol is more likely to be checked, but in states with more African-Americans, more prescriptions were written, whereas in states with more Hispanics, fewer statin prescriptions were written. CONCLUSION: Variations across states in insurance and racial/ethnicity mix are associated with variations in hyperlipidemia management; less-insured states may be less effective whereas states with more private, Medicare, or Medicaid coverage may not be more effective. In states with proportionately more African-Americans vs. Hispanics, lipid medications may be prescribed differently. Our findings warrant further investigations. (C) 2013 National Lipid Association. All rights reserved.
引用
收藏
页码:675 / 682
页数:8
相关论文
共 29 条
  • [1] [Anonymous], 2009, Highlights from Education at a Glance, P19
  • [2] [Anonymous], BROOKINGS PAPERS EC
  • [3] Bunce VictoriaCraig., 2008, Health Insurance Mandates in the States 2008
  • [4] Centers for Disease Control and Prevention, 2010, OV OB BMI 2010 WEIGH
  • [5] Centers for Disease Control and Prevention, 2009, CHOL AW 2009 AD WHO
  • [6] Results of the National Cholesterol Education (NCEP) Program Evaluation Project Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations
    Davidson, MH
    Maki, KC
    Pearson, TA
    Pasternak, RC
    Deedwania, PC
    McKenney, JM
    Fonarow, GC
    Maron, DJ
    Ansell, BJ
    Clark, LT
    Ballantyne, CM
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (04) : 556 - 563
  • [7] The Large Social Value Resulting From Use Of Statins Warrants Steps To Improve Adherence And Broaden Treatment
    Grabowski, David C.
    Lakdawalla, Darius N.
    Goldman, Dana P.
    Eber, Michael
    Liu, Larry Z.
    Abdelgawad, Tamer
    Kuznik, Andreas
    Chernew, Michael E.
    Philipson, Tomas
    [J]. HEALTH AFFAIRS, 2012, 31 (10) : 2276 - 2285
  • [8] Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, R
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Cleeman, JI
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    Keller, SA
    Jehle, AJ
    [J]. CIRCULATION, 2002, 106 (25) : 3143 - 3421
  • [9] Holahan J, 1997, NEW FEDERALISM ISS A, V3
  • [10] State variation in medicaid spending: Hard to justify
    Holahan, John
    [J]. HEALTH AFFAIRS, 2007, 26 (06) : W667 - W669